期刊文献+

鲑鱼降钙素穴位注射配合护理干预骨质疏松疼痛疗效分析 被引量:7

Effect Analysis of Point Injection with Salmon Calcitonin Combined with Nursing Intervention in Treating Pain Due to Osteoporosis
原文传递
导出
摘要 目的:观察鲑鱼降钙素穴位注射配合护理干预骨质疏松疼痛的临床疗效。方法:选取78例骨质疏松疼痛患者为研究对象,随机分为对照组和治疗组各39例。2组均进行骨质疏松症疼痛护理,对照组予鲑鱼降钙素肌肉注射,治疗组予鲑鱼降钙素双侧肾俞、脾俞穴位注射。观察2组治疗前后视觉模拟评分法(VAS)评分和健康调查简表(SF-36)评分的变化,记录疼痛缓解时间。结果:治疗后,2组VAS评分均较治疗前降低(P<0.05);治疗组的VAS评分低于对照组(P<0.05)。对照组疼痛缓解时间(14.21±4.02)天,治疗组疼痛缓解时间(10.13±3.45)天,2组比较,差异有统计学意义(P<0.05)。治疗后,2组生理职能、躯体疼痛及活力等6项评分均较治疗前升高(P<0.05);治疗组社会功能、躯体疼痛、活力及总体健康评分均高于对照组(P<0.05);2组生理功能、生理职能、情感职能及精神健康评分比较,差异均无统计学意义(P>0.05)。结论:鲑鱼降钙素穴位注射联合护理干预骨质疏松疼痛患者,能更有效地缓解疼痛,提高生活质量。 Objective:To observe the effect of point injection with salmon calcitonin combined with nursing intervention in treating patients with pain due to osteoporosis. Methods:Selected 78 patients with pain due to osteoporosis as study object and divided them into the control group and the treatment group being 39 cases in each randomly. The two groups were given nursing intervention for reliving pain due to osteoporosis, and the control group was given point injection with salmon calcitonin while the treatment group was given injection with salmon calcitonin at bilateral Shenshu points and Pishu points. Observed change of visual analogue scale(VAS) score and short from health survey SF-36(SF-36) score of the two groups before and after treatment, recorded time of pain relief. Results :After treatment,VAS scores of the two groups were both lower than those before treatment(P〈0.05),and scores of the treatment group were lower than those of the control group(P〈0.05). The time of pain relief was 14.21±4.02 days in the control group and was 10.13±3.45 days in the treatment group,the difference being significant(P〈0.05). After treatment,scores of physiological role,somatic pain, activity and so on of the two groups were higher than those before treatment(P〈0.05),and scores of social function,somatic pain, activity and general health scores of the treatment group were all higher than those before treatment(P〈0.05). Comparing scores of physiological function, physiological role,emotional role and mental health of the two groups,the differences were not significant(P〈0.05).Conclusion: Point injection with salmon calcitonin combined with nursing intervention can relieve pain effectively, and improve quality of life in treating patients with pain due to osteoporosis.
作者 李鹏鸟 徐丹
出处 《新中医》 CAS 2017年第7期139-141,共3页 New Chinese Medicine
关键词 骨质疏松症 疼痛 鲑鱼降钙素 穴位注射 护理 视觉模拟评分法(VAS) 健康调查简表(SF-36) Osteoporosis Pain Salmon calcitonin Point injection Nursing Visual analogue scale(VAS) Short from health survey SF-36(SF-36)
  • 相关文献

参考文献5

二级参考文献178

  • 1Li X,Ominsky MS,Warmington KS,et al.Sclerostin antibody treatment increases bone formation,bone mass,and hone strength in a rat model of postmenopausal osteoporosis.J Bone Miner Res,2009,24(4):578-588.
  • 2Eddleston A,Marenzana M,Moore AR,et al.A short treatment with an antibody to sclerostin can inhibit bone loss in an ongoing model of colitis.J Bone Miner Res,2009,24(10):1662-1671.
  • 3Li X,Warmington KS,Niu QT,et al.Inhibition of sclerostin by monoclonal antibody increases bone formation,bone mass and bone strength in aged male rats.J Bone Miner Res,2010.
  • 4Ominsky MS,Vlasseros F,Jolette J,et al.Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation,bone mineral density,and bone strength.J Bone Miner Res,2010,25(5):948-959.
  • 5Bone HG,Mcclung MR,Roux C,et al.Odanacatib,a cathepsin-K inhibitor for osteoporosis:a two-year study in postmenopausal women with low bone density.J Bone Miner Res,2010,25(5):937-947.
  • 6Scott K,Pennypacker B,Samadfan R,et al.Odanacatib Increases Bone Strength and Maintains Bone Quality in Estrogen Deficient Adult Rhesus Monkeys.Montréal,Quebéc,Canada:2008.
  • 7Bottiger D,Darpo B,Grabowska U,et al.Cathepsin K Inhibitor,MIV-701,Suppresses Bone Resorption Markers in Healthy PMW:Results of a Phase I Clinical Trial.Montréal,Quebéc,Canada:2008.
  • 8Neer RM,Arnaud CD,Zanchetta JR,et al.Effect of parathyroid hormone(1-34)on fractures and bone mineral density in postmenopausal women with osteoporosis.N Engl J Med,2001,344(19):1434-1441.
  • 9Greenspan SL,Bone HG,Ettinger MP,et al.Effect of recombinant human parathyroid hormone(1-84)on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis:a randomized trial.Ann Intern Med,2007,146(5):326-339.
  • 10Black DM,Greenspan SL,Ensrud KE,et al.The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.N Engl J Med,2003,349(13):1207-1215.

共引文献1924

同被引文献136

引证文献7

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部